Tenofovir versus placebo to prevent perinatal transmission of hepatitis B

G Jourdain, N Ngo-Giang-Huong… - … England Journal of …, 2018 - Mass Medical Soc
Background Pregnant women with an elevated viral load of hepatitis B virus (HBV) have a
risk of transmitting infection to their infants, despite the infants' receiving hepatitis B immune …

Management of chronic HBV‐HDV patients chronic HBV‐HDV infection: A review on new management options

M Buti, A Gonzalez, M Riveiro‐Barciela… - United European …, 2024 - Wiley Online Library
Hepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic
viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago …

[HTML][HTML] Liver diseases: perspective from the Philippines

ED Ornos, KJ Murillo, JP Ong - Annals of Hepatology, 2023 - Elsevier
Liver diseases are a major cause of morbidity and mortality globally. In the Philippines, a
lower middle-income country in Southeast Asia, liver diseases accounted for 27.3 cases per …

[HTML][HTML] Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa

Y Shimakawa, R Njie, G Ndow, M Vray, PS Mbaye… - Journal of …, 2018 - Elsevier
Background & Aims To eliminate hepatitis B virus (HBV) infection, it is essential to scale up
antiviral treatment through decentralized services. However, access to the conventional …

Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience

N Chotun, W Preiser, CJ Van Rensburg, P Fernandez… - PloS one, 2017 - journals.plos.org
Background & aims Elimination of HIV and syphilis mother-to-child transmission (MTCT) has
received much attention but little consideration has been given to the possibility of …

Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical study

O Yoshida, SMF Akbar, Y Imai, T Sanada… - Hepatology …, 2023 - Wiley Online Library
Aims HBsAg loss with anti‐HBs acquisition is considered a functional cure and ideal
treatment goal for patients with CHB. Our group have reported the efficacy of therapeutic …

[HTML][HTML] Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report

B Aygen, AM Demir, M Gümüş, O Karabay… - The Turkish Journal …, 2018 - ncbi.nlm.nih.gov
This consensus report includes expert opinions and recommendations regarding the
screening, and if necessary, the follow-up, prophylaxis, and treatment of hepatitis B before …

[HTML][HTML] Elimination of mother-to-infant transmission of hepatitis B virus: 35 years of experience

FT Lu, YH Ni - Pediatric Gastroenterology, Hepatology & Nutrition, 2020 - ncbi.nlm.nih.gov
Chronic hepatitis B viral (HBV) infection remains a major health threat, especially in high-
prevalence areas. Most infants infected by mother-to-infant HBV transmission become …

[HTML][HTML] Exploring risk factors and transmission dynamics of Hepatitis B infection among Indian families: Implications and perspective

S Athalye, N Khargekar, S Shinde, T Parmar… - Journal of Infection and …, 2023 - Elsevier
Abstract Introduction Hepatitis B virus (HBV) is global health problem. Family members of
HBV infected people are considered as high-risk groups due to frequent household …

[HTML][HTML] Clinical study of hepatitis B vaccine in achieving hepatitis B surface antibody seroconversion in patients with functional cure

Y Liu, S Ren, L Ma, X Lin, H Li, J Lu, Z Cao… - Brazilian Journal of …, 2024 - SciELO Brasil
Abstract Hepatitis B Surface Antigen (HBsAg) seroclearance is the highest treatment goal
recommended by the current guidelines for hepatitis B. Levels of antibodies to HBsAg (anti …